Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126942532 | 12694253 | 2 | F | 20160919 | 20160829 | 20160923 | PER | US-PFIZER INC-2016403951 | PFIZER | 67.00 | YR | F | Y | 52.00000 | KG | 20160923 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126942532 | 12694253 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 37.5 MG, 1X/DAY | Y | 20699 | 37.5 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
| 126942532 | 12694253 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 1X/DAY | Y | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
| 126942532 | 12694253 | 3 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG, 1X/DAY | Y | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
| 126942532 | 12694253 | 4 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 1X/DAY | Y | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
| 126942532 | 12694253 | 5 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG, 1X/DAY | Y | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE | QD | |||||
| 126942532 | 12694253 | 6 | C | ASACOL | MESALAMINE | 1 | 1600 MG, 2X/DAY | 0 | 1600 | MG | TABLET | BID | |||||||
| 126942532 | 12694253 | 7 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MG, DAILY | 0 | 25 | MG | ||||||||
| 126942532 | 12694253 | 8 | C | XANAX | ALPRAZOLAM | 1 | 0.25 MG, 2X/DAY | 0 | .25 | MG | BID | ||||||||
| 126942532 | 12694253 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126942532 | 12694253 | 10 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Rectal | 100MG/60ML, 1X/DAY | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126942532 | 12694253 | 1 | Anxiety |
| 126942532 | 12694253 | 2 | Depression |
| 126942532 | 12694253 | 6 | Colitis ulcerative |
| 126942532 | 12694253 | 7 | Hypertension |
| 126942532 | 12694253 | 8 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126942532 | 12694253 | Chills | |
| 126942532 | 12694253 | Disorientation | |
| 126942532 | 12694253 | Dizziness | |
| 126942532 | 12694253 | Drug ineffective | |
| 126942532 | 12694253 | Drug intolerance | |
| 126942532 | 12694253 | Paraesthesia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126942532 | 12694253 | 5 | 20160608 | 20160816 | 0 | |
| 126942532 | 12694253 | 6 | 20160608 | 0 |